Abstract

A major limitation in the development of effective scaffolds for bone regeneration has been the limited vascularization of the regenerating tissue. Here, we propose the development of a novel calcium phosphate cement (CPC)-based scaffold combining the properties of mesoporous silica (MS) with recombinant human bone morphogenic protein-2 (rhBMP-2) to facilitate vascularization and osteogenesis. Specifically, the development of a custom MS/CPC paste allowed the three-dimensional (3D) printing of scaffolds with a defined macroporous structure and optimized silicon (Si) ions release profile to promote the ingrowth of vascular tissue at an early stage after implantation in support of tissue viability and osteogenesis. In addition, the scaffold microstructure allowed the prolonged release of rhBMP-2, which in turn significantly stimulated the osteogenesis of human bone marrow stromal cells in vitro and of bone regeneration in vivo as shown in a rabbit femur defect repair model. Thus, the combination MS/CPC/rhBMP-2 scaffolds might provide a solution to issues of tissue necrosis during the regeneration process and therefore might be able to be readily developed into a useful tool for bone repair in the clinic.

Highlights

  • A major limitation in the development of effective scaffolds for bone regeneration has been the limited vascularization of the regenerating tissue

  • From mesoporous silica (MS) powders have been verified to stimulate the osteogenic differentiation of human bone marrow stromal cells[10] and enhance the proangiogenesis of endothelial cells (ECs)[11,12,13]

  • The results showed that the cells exhibited good growth and survival in the extraction medium of each group and that the incorporation of recombinant human bone morphogenic protein-2 (rhBMP-2) showed no significant effect on the cell viability

Read more

Summary

Introduction

A major limitation in the development of effective scaffolds for bone regeneration has been the limited vascularization of the regenerating tissue. We propose the development of a novel calcium phosphate cement (CPC)-based scaffold combining the properties of mesoporous silica (MS) with recombinant human bone morphogenic protein-2 (rhBMP-2) to facilitate vascularization and osteogenesis. The development of a custom MS/CPC paste allowed the three-dimensional (3D) printing of scaffolds with a defined macroporous structure and optimized silicon (Si) ions release profile to promote the ingrowth of vascular tissue at an early stage after implantation in support of tissue viability and osteogenesis. The combination MS/CPC/rhBMP-2 scaffolds might provide a solution to issues of tissue necrosis during the regeneration process and might be able to be readily developed into a useful tool for bone repair in the clinic. Bioactive mesoporous calcium silicate/calcium phosphate cement (MCS/CPC) scaffolds with well interconnected macropores have been successfully fabricated by our laboratory using three-dimensional (3D) extrusion-based printing[7]. The formation mode of new blood vessels inside the straight pores fabricated using the 3D printing technique with the concomitant release of Si ions has not yet been verified and analysed

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call